NCT04867278

Brief Summary

One complication that can occur after surgery on the acetabulum is the development of bone in abnormal places such as muscle and soft tissues. There is some evidence that a single dose of radiation to the surgical site within 3 days of surgery will prevent this abnormal bone from forming. However, there are no high quality studies proving that radiation works any better than doing nothing at all. The purpose of our study is to determine whether there is a difference in abnormal bone formation after acetabular surgery when patients are treated with external beam irradiation versus no treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
117

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 30, 2021

Completed
9 days until next milestone

Study Start

First participant enrolled

May 9, 2021

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
12 months until next milestone

Results Posted

Study results publicly available

December 16, 2024

Completed
Last Updated

December 16, 2024

Status Verified

November 1, 2024

Enrollment Period

2.6 years

First QC Date

April 21, 2021

Results QC Date

August 19, 2024

Last Update Submit

November 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Severe HO Formation

    Severe HO formation classified as Brooker class III-IV.

    3 months post-op

Secondary Outcomes (1)

  • Number of Participants With Any HO Formation

    3 months post-op

Study Arms (2)

External Beam Radiation (XRT) with Debridement

EXPERIMENTAL

Patients will receive gluteus minimus debridement in the OR, which is the standard of care at Shock Trauma. If randomized to the treatment group, patients that undergo surgical fixation of an acetabular fracture via a posterior or combined anterior and posterior approach will undergo a single fraction of external beam radiotherapy to the surgical site within 72 hours of surgery. This treatment is currently the standard procedure performed for all patients who undergo a posterior or combined approach at our institution.

Procedure: External Beam Radiation (XRT)Procedure: Debridement

Debridement Alone (Control)

ACTIVE COMPARATOR

The control treatment arm will only include gluteus minimus debridement in the OR and will not receive XRT.

Procedure: Debridement

Interventions

Patients that undergo surgical fixation of an acetabular fracture will receive debridement and a single fraction of external beam radiotherapy to the surgical site within 72 hours of surgery.

External Beam Radiation (XRT) with Debridement
DebridementPROCEDURE

Gluteus minimus debridement in the OR

Debridement Alone (Control)External Beam Radiation (XRT) with Debridement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult aged 18+ with an acute acetabular fracture
  • Indicated for surgical fixation via a posterior or combined anterior and posterior approach

You may not qualify if:

  • Contraindication to radiotherapy such as history of cancer/RT
  • Patients that are getting an acute total hip arthroplasty at the time of fixation of the acetabular fracture
  • Not English speaking
  • Not a Maryland resident or likely to have difficulty returning for post-op follow up(s) (i.e. homeless, incarceration)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland, Shock Trauma Center

Baltimore, Maryland, 21201, United States

Location

Related Publications (5)

  • Sagi HC, Jordan CJ, Barei DP, Serrano-Riera R, Steverson B. Indomethacin prophylaxis for heterotopic ossification after acetabular fracture surgery increases the risk for nonunion of the posterior wall. J Orthop Trauma. 2014 Jul;28(7):377-83. doi: 10.1097/BOT.0000000000000049.

    PMID: 24625922BACKGROUND
  • Matta JM, Siebenrock KA. Does indomethacin reduce heterotopic bone formation after operations for acetabular fractures? A prospective randomised study. J Bone Joint Surg Br. 1997 Nov;79(6):959-63. doi: 10.1302/0301-620x.79b6.6889.

    PMID: 9393912BACKGROUND
  • Karunakar MA, Sen A, Bosse MJ, Sims SH, Goulet JA, Kellam JF. Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum. J Bone Joint Surg Br. 2006 Dec;88(12):1613-7. doi: 10.1302/0301-620X.88B12.18151.

    PMID: 17159174BACKGROUND
  • Moore KD, Goss K, Anglen JO. Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: a randomised, prospective study. J Bone Joint Surg Br. 1998 Mar;80(2):259-63. doi: 10.1302/0301-620x.80b2.8157.

    PMID: 9546456BACKGROUND
  • Burd TA, Lowry KJ, Anglen JO. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures. J Bone Joint Surg Am. 2001 Dec;83(12):1783-8. doi: 10.2106/00004623-200112000-00003.

    PMID: 11741055BACKGROUND

MeSH Terms

Conditions

Ossification, Heterotopic

Interventions

Debridement

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Limitations and Caveats

A limitation of the current study is the fourteen-patient crossover from the XRT treatment arm to no XRT. These 14 patients were randomized to the XRT group, but did not receive XRT at all, thus crossing over to the no XRT group. Additionally, although the sample size was adequately powered, there were a relatively few number of study events. Lastly, although the study is multicenter, it is only 2 centers.

Results Point of Contact

Title
Dr. Adam Boissonneault
Organization
Emory University

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the UM SOM's Division of Orthopaedic Traumatology and Chief of Orthopaedic Traumatology and CHief of Orthopaedics for the University of Maryland Medical Center's (UMMS) R Adams Cowley Shock Trauma Center

Study Record Dates

First Submitted

April 21, 2021

First Posted

April 30, 2021

Study Start

May 9, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

December 16, 2024

Results First Posted

December 16, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations